正业生物 ZYBT 深 沪
已收盘 08-07 16:00:00 美东时间
1.89
-0.200
-9.57%
华盛通- 最 高4.29
- 今 开2.38
- 成交量 1302.14万股
- 最 低 1.22
- 昨 收 2.09
- 总市值 0
- 52周最高 12.03
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.6155
- 委 比 -94.87%
- 总股本 --
- 历史最高 14.30
- 量 比 0
- 振 幅 146.89%
- 历史最低 0.6155
- 每 手 1
- 风险率 2.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Zhengye Biotechnology Stock Plunges Following 322% Rally In Volatile Reversal
Zhengye Biotechnology stock plunges after a 322% rally as the company finds no undisclosed catalyst and contacts Nasdaq.
07-22 23:59
Dow Surges 300 Points; General Motors Posts Upbeat Earnings
US stocks rise with Dow Jones up 0.57% and NASDAQ climbing 0.69%. GM reports strong Q2 results and Utz Brands announces acquisition. Oil and gold up.
07-21 22:23
Nasdaq Surges 1%; Domino’s Shares Gain After Q2 results
US stocks higher, Nasdaq up 1% as Dow rises 0.25%. Domino's Pizza stock increases 4% on revenue beat. Oil down 0.8% and gold down 0.1%.
07-20 21:54
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 76.7% to $0.18 du...
04-13 20:05
Zhengye Biotechnology Adopts Dual-Class Share Structure, Effective April 7
Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on
04-06 21:26
Zhengye Biotechnology Holding Releases 2026 Chairman's Shareholder
Dear Shareholders,As we enter 2026, on behalf of the management of Zhengye Biotechnology Holding Limited, I am proud of the milestones we achieved in 2025 and would like to share our strategic vision for 2026 and the
02-10 21:38
Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F
Zhengye Biotechnology Holding Limited received a NASDAQ notice due to failing to file its 2024 annual report on time. The company has 60 days to submit a compliance plan and may gain up to 180 days to meet listing requirements. The notice does not immediately affect its stock listing.
2025-05-23 20:05
正业生物登陆美股市场 开盘大涨22%
周二，中国兽用疫苗供应商正业生物(ZYBT.US)登陆美股市场，截至发稿，大涨超22%，报4.88美元。该公司首次公开募股150万股，每股定价4美元。据悉，正业生物成立于2004年，专注于兽用疫苗的研究、开发、制造和销售，重点是家畜疫苗。其产品组合目前包含43种兽用疫苗，涵盖猪和牛等牲畜的所有主要疫苗，它还在开发狗等家养动物的疫苗。正业生物的产品在中国29个省级地区销售，并出口到越南、巴基斯坦、埃及等海外国家。数据显示，该公司截至2023年12月31日的12个月销售额为2900万美元。 海量资讯、精准解读，尽在新浪财经APP 责任编辑：郭明煜
2025-01-07 23:58
